Literature DB >> 17902123

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival.

Timothy J S Cross1, Charalambos G Antoniades, Paolo Muiesan, Thawab Al-Chalabi, Varuna Aluvihare, Kosh Agarwal, Bernard C Portmann, Mohammed Rela, Nigel D Heaton, John G O'Grady, Michael A Heneghan.   

Abstract

With increased demand for liver transplantation (LT), outcomes of older recipients have been subjected to greater scrutiny, as previous studies have demonstrated poorer survival outcomes. Outcomes of 77 patients aged>65 yr (group 1) who underwent transplantation between 1988 and 2003 at King's College Hospital, London, were compared with all recipients aged between 60 and 64 yr (group 2, n=137) and 202 time-matched control patients with chronic liver disease aged between 18-59 yr (group 3). Patient survival at 30-days for groups 1, 2, and 3 were 99%, 94%, and 94%, respectively (P=not significant [NS]). At 1-yr, survival in the 3 groups was 82%, 86%, and 83%, respectively (P=NS), and at 5-yr patient survival was comparable (73%, 80%, and 78%, respectively) (P=NS). Episodes of acute cellular rejection (ACR) were fewer in the older cohorts (43% vs. 45% vs. 61%, P=0.0016), although there was no significant difference identified in the numbers of patients in each group who experienced ACR (P=0.16). A similar but nonsignificant trend was identified for rates of chronic rejection among the groups. In conclusion, these data suggest that survival of patients over 60 and 65 yr undergoing LT is satisfactory, at least in the first 5-yr posttransplantation. In addition, patients over 65 yr experience less rejection, with good graft survival. Thus, LT should not be denied to patients>65 yr on the basis of age alone, once a comprehensive screen for comorbidity has been undertaken. Copyright (c) 2007 AASLD.

Entities:  

Mesh:

Year:  2007        PMID: 17902123     DOI: 10.1002/lt.21181

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  23 in total

1.  Outcome of acute liver failure in the elderly.

Authors:  Frank V Schiødt; Raymond T Chung; Michael L Schilsky; J Eileen Hay; Erik Christensen; William M Lee
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

2.  Long-term quality of life of liver transplant recipients beyond 60 years of age.

Authors:  G Werkgartner; D Wagner; S Manhal; A Fahrleitner-Pammer; H J Mischinger; M Wagner; R Grgic; R E Roller; D Kniepeiss
Journal:  Age (Dordr)       Date:  2013-03-26

Review 3.  CON: Patients of Advanced Age Should Not Routinely Undergo Liver Transplantation.

Authors:  Avash Kalra; Michael Kriss; Prashanth Francis; J P Norvell
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-09-02

4.  Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.

Authors:  Connie W Wang; Kenneth E Covinsky; Sandy Feng; Hilary Hayssen; Dorry L Segev; Jennifer C Lai
Journal:  Liver Transpl       Date:  2015-11-06       Impact factor: 5.799

Review 5.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 6.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

7.  Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.

Authors:  Gregory C Wilson; R Cutler Quillin; Koffi Wima; Jeffrey M Sutton; Richard S Hoehn; Dennis J Hanseman; Ian M Paquette; Flavio Paterno; E Steve Woodle; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2014-08-06       Impact factor: 3.647

8.  It's a man's world: does orthotopic liver transplantation in the elderly male confer an additional risk on survival?

Authors:  Eoin Slattery; John E Hegarty; P Aiden McCormick
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

9.  Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years.

Authors:  Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 10.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.